STOCK TITAN

Elixxer Announces Appointment of Mark Romano as a Director

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management

Elixxer (TSXV: ELXR) has announced changes to its Board of Directors. Mark Romano, a senior executive with over 40 years of experience in technical leadership, program management, and business operations, has been appointed as an independent Director. He replaces Jeremy Green, who has resigned from his position on the Board.

Elixxer (TSXV: ELXR) ha annunciato cambiamenti nel suo Consiglio di Amministrazione. Mark Romano, un dirigente senior con oltre 40 anni di esperienza in leadership tecnica, gestione di programmi e operazioni commerciali, è stato nominato Direttore indipendente. Sostituisce Jeremy Green, che si è dimesso dalla sua posizione nel Consiglio.

Elixxer (TSXV: ELXR) ha anunciado cambios en su Junta Directiva. Mark Romano, un ejecutivo senior con más de 40 años de experiencia en liderazgo técnico, gestión de programas y operaciones comerciales, ha sido nombrado como Director independiente. Reemplaza a Jeremy Green, quien ha renunciado a su puesto en la Junta.

Elixxer (TSXV: ELXR)는 이사회의 변화를 발표했습니다. Mark Romano는 기술 리더십, 프로그램 관리 및 비즈니스 운영에서 40년 이상의 경험을 가진 수석 임원으로 독립 이사로 임명되었습니다. 그는 이사회에서 사임한 Jeremy Green을 대신합니다.

Elixxer (TSXV: ELXR) a annoncé des changements au sein de son Conseil d'Administration. Mark Romano, un cadre supérieur avec plus de 40 ans d'expérience en leadership technique, gestion de programme et opérations commerciales, a été nommé Directeur indépendant. Il remplace Jeremy Green, qui a démissionné de son poste au Conseil.

Elixxer (TSXV: ELXR) hat Änderungen im Vorstand bekannt gegeben. Mark Romano, ein leitender Angestellter mit über 40 Jahren Erfahrung in technischer Führung, Programmmanagement und Unternehmensoperationen, wurde als unabhängiger Direktor ernannt. Er ersetzt Jeremy Green, der von seiner Position im Vorstand zurückgetreten ist.

Positive
  • Appointment of experienced executive with 40+ years in technical leadership and operations
Negative
  • None.

Toronto, Ontario--(Newsfile Corp. - January 23, 2025) -  Elixxer Ltd. (TSXV: ELXR) ("Elixxer" or the "Company") is pleased to announce that Mark Romano has been appointed as an independent Director of the Company to replace Jeremy Green who has resigned.

Mr Romano is an accomplished senior executive with over 40 years of experience in technical leadership, program management, and business operations. We thank Mr. Green for his time and work on the Company's Board and wish him well in his future endeavours.

About Elixxer Ltd.

Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSXV: ELXR) and the US OTC-Pink exchange (OTC Pink: ELIXF). Elixxer is an investment company with investments in Canada and other countries and is currently looking for new high growth opportunities to invest in.

For further information please contact:

Karim Mecklai, Chief Executive Officer, 416-877-3153

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/238206

FAQ

Who is the new director appointed to Elixxer's (ELXR) board in January 2025?

Mark Romano was appointed as an independent Director of Elixxer (ELXR) in January 2025, replacing Jeremy Green who resigned from the position.

What experience does Mark Romano bring to Elixxer's (ELXR) board?

Mark Romano brings over 40 years of experience in technical leadership, program management, and business operations to Elixxer's board.

Which board member resigned from Elixxer (ELXR) in January 2025?

Jeremy Green resigned from his position as a Director on Elixxer's board in January 2025.

When did Elixxer (ELXR) announce its latest board member change?

Elixxer announced the appointment of Mark Romano and the resignation of Jeremy Green on January 23, 2025.

ELIXXER LTD

OTC:ELIXF

ELIXF Rankings

ELIXF Latest News

ELIXF Stock Data

10.14M
11.34M
32.04%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Montreal